Dr. George D. Demetri, MD

Accepting New Patients

(No ratings)

Specializes in: Medical Oncology and Adult Oncology

Stanford University School of Medicine

Professional interests include: developmental therapeutics, soft tissue sarcoma, sarcoma (bone and soft tissue cancer), and more.

450 BROOKLINE AVENUE
Boston, MA 02215

1-877-442-3324

Dr. George D. Demetri, MD is a medical oncologist in Boston, MA specializing in medical oncology and adult oncology. He graduated from Stanford University School of Medicine. Dr. George D. Demetri, MD is affiliated with Dana-Farber Cancer Institute and DANA-FARBER CANCER INSTITUTE, INC.

Office Locations

Address:

450 BROOKLINE AVENUE
Boston, MA 02215

In The News (see more mentions in the news)

“Prof. George D. Demetri, MD, is a Professor of Medicine at Harvard Medical School, Director at the Center for Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute (DFCI), and Quick Family...”—"Tessellate BIO, an Emerging Precision Oncology Company, Announces the Appointment of World-Leading Scientists to its Scientific Advisory Board", KRON4, November 2023

“Bertagnolli became a surgeon when women were just starting to enter the field in substantial numbers, said George D. Demetri, a medical oncologist and director of the Sarcoma Center at Dana-Farber.”—"For new NCI director, work turns personal: She is diagnosed with cancer", Washington Post, December 2022

“The fact that it's a long-term therapy means drug companies can make a lot of money, even on relatively rare diseases, said Dr. George Demetri, director of the Sarcoma Center at Dana-Farber Cancer...”—"'Game-changer' cancer drug celebrates 20 years. Gleevec turned a death sentence into a chronic disease for many.", USA Today, May 2021

Education & Training

Dr. George D. Demetri, MD graduated from Stanford University School of Medicine. He completed residency at University of Washington Affiliated Hospitals. He is certified by the Board Certification:Internal Medicine and has a state license in Massachusetts.

Medical School: Stanford University School of Medicine

Residency: University of Washington Affiliated Hospitals

Board Certification: Board Certification:Internal Medicine (1986)

Licensed In: Massachusetts

Affiliations & Hospitals

Dr. George D. Demetri, MD is associated with these hospitals and organizations:

Dana-Farber Cancer Institute

DANA-FARBER CANCER INSTITUTE, INC

Ratings & Reviews

Dr. George D. Demetri, MD does not have any reviews yet, be the first to leave a review of Dr. George D. Demetri, MD here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. George D. Demetri, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

**Payments by Company**
Blueprint Medicines Corporation	$1,213,409 $1,213,409
EMD Serono, Inc.	$81,481 Avelumab $5,514	$75,967
Aadi Bioscience, Inc.	$52,099 FYARRO $52,099
Bayer HealthCare Pharmaceuticals Inc.	$49,272 Stivarga $33,122	Vitrakvi $8,800	Non-Covered $4,550	$2,800
Daiichi Sankyo Inc.	$39,125 $39,125
Other	$149,937 Non-Covered Product $26,691	KRAZATI $12,495	YONDELIS $12,038	SUTENT $7,610	Halaven $3,707	Other $87,396

**Types of Payments**
Consulting Fee	$1,506,123
Travel and Lodging	$37,094
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program	$23,215
Honoraria	$12,050
Food and Beverage	$5,442
Other	$1,399

Research Payments

Dr. George D. Demetri, MD has received 112 research payments totaling $11,902,428.

Ownership and Interest Payments

This table describes ownership payments received by Dr. George D. Demetri, MD.

Blueprint Medicines Corporation	2023	$536,098.88	Physician Covered Recipient	Publicly held company equity
Blueprint Medicines Corporation	2021	$381,525.82	Physician Covered Recipient	Publicly held company equity
Blueprint Medicines Corporation	2022	$254,623.72	Physician Covered Recipient	Publicly held company equity
Blueprint Medicines Corporation	2020	$147,140.80	Physician Covered Recipient	Publicly held company equity

Biography

Dr. George Demetri's areas of specialization are adult oncology and medical oncology. His clinical interests include soft tissue sarcoma, developmental therapeutics, and bone cancer (osteosarcoma). Dr. Demetri is affiliated with Dana-Farber Cancer Institute. Before performing his residency at a hospital affiliated with the University of Washington, Dr. Demetri attended Stanford University School of Medicine. His practice in Boston, MA is open to new patients as reported by Doctor.com.